Ask a Patient® Health News: Drugs & Treatments

Ask a Patient® Health News: Drugs & Treatments

Share this post

Ask a Patient® Health News: Drugs & Treatments
Ask a Patient® Health News: Drugs & Treatments
November 12, 2023: Zepbound, Cosentyx, Keytruda, Stelara "generic," Inderal and hypoglycemia; CRISPR treatment potential; anxiety herb; questioning osteoporosis drug treatments for reducing fractures

November 12, 2023: Zepbound, Cosentyx…

Nov 12, 2023

Share this post

Ask a Patient® Health News: Drugs & Treatments
Ask a Patient® Health News: Drugs & Treatments
November 12, 2023: Zepbound, Cosentyx, Keytruda, Stelara "generic," Inderal and hypoglycemia; CRISPR treatment potential; anxiety herb; questioning osteoporosis drug treatments for reducing fractures

In the first two weeks of November, the FDA made four major drug approvals and reported on two significant drug label changes.

Read →
Comments
User's avatar
© 2025 AskaPatient.com
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share